Fig. 2From: Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseasesaPS/PT antibodies in ATI negative and ATI-positive sera. a W2 b W14. aPS/PT phosphatidylserine-dependent antiprothrombin antibodies, ATI antibodies to infliximab, W2 second week of the biological treatment, W14 14th week of the biological treatmentBack to article page